Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 1
2005 1
2010 1
2012 1
2013 1
2014 1
2016 1
2017 1
2018 4
2019 4
2020 6
2021 4
2022 3
2023 2
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Post-COVID-19 Hyposmia Does Not Exhibit Main Neurodegeneration Markers in the Olfactory Pathway.
Schirinzi T, Maftei D, Maurizi R, Albanese M, Simonetta C, Bovenzi R, Bissacco J, Mascioli D, Boffa L, Di Certo MG, Gabanella F, Francavilla B, Di Girolamo S, Mercuri NB, Passali FM, Lattanzi R, Severini C. Schirinzi T, et al. Among authors: boffa l. Mol Neurobiol. 2024 Apr 4. doi: 10.1007/s12035-024-04157-w. Online ahead of print. Mol Neurobiol. 2024. PMID: 38570429
Trimetazidine Improves Mitochondrial Dysfunction in SOD1G93A Cellular Models of Amyotrophic Lateral Sclerosis through Autophagy Activation.
Salvatori I, Nesci V, Spalloni A, Marabitti V, Muzzi M, Zenuni H, Scaricamazza S, Rosina M, Fenili G, Goglia M, Boffa L, Massa R, Moreno S, Mercuri NB, Nazio F, Longone P, Ferri A, Valle C. Salvatori I, et al. Among authors: boffa l. Int J Mol Sci. 2024 Mar 13;25(6):3251. doi: 10.3390/ijms25063251. Int J Mol Sci. 2024. PMID: 38542223 Free PMC article.
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs.
Capuano R, Prosperini L, Altieri M, Lorefice L, Fantozzi R, Cavalla P, Guaschino C, Radaelli M, Cordioli C, Nociti V, Boffa L, Ragonese P, Di Gregorio M, Pinardi F, Torri Clerici V, De Luca G, Gajofatto A, Paolicelli D, Tortorella C, Gasperini C, Solaro C, Cocco E, Bisecco A, Gallo A. Capuano R, et al. Among authors: boffa l. Mult Scler. 2023 Jun;29(7):856-865. doi: 10.1177/13524585231167515. Epub 2023 May 11. Mult Scler. 2023. PMID: 37165941 Free PMC article.
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction.
Schirinzi T, Lattanzi R, Maftei D, Grillo P, Zenuni H, Boffa L, Albanese M, Simonetta C, Bovenzi R, Maurizi R, Loccisano L, Vincenzi M, Greco A, Di Girolamo S, Mercuri NB, Passali FM, Severini C. Schirinzi T, et al. Among authors: boffa l. Brain Behav Immun. 2023 Feb;108:302-308. doi: 10.1016/j.bbi.2022.12.017. Epub 2022 Dec 19. Brain Behav Immun. 2023. PMID: 36549578 Free PMC article.
mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis.
Di Filippo M, Cordioli C, Malucchi S, Annovazzi P, Cavalla P, Torri Clerici V, Ragonese P, Nociti V, Radaelli M, Laroni A, Buttari F, Lorefice L, Ferraro D, Gajofatto A, Prosperini L, Fantozzi R, Boffa L, Lanzillo R, Moccia M, Clerico M, De Luca G, Tomassini V, Calabrese M, Borrelli A, Paolicelli D, Maniscalco GT, Gazzola P, Gallo A, Solaro C, Cocco E, Gasperini C, Tortorella C; RIREMS (Rising Researchers in MS) group. Di Filippo M, et al. Among authors: boffa l. J Neurol Neurosurg Psychiatry. 2022 Apr;93(4):448-450. doi: 10.1136/jnnp-2021-327200. Epub 2021 Aug 18. J Neurol Neurosurg Psychiatry. 2022. PMID: 34408003 No abstract available.
26 results